Pharmacokinetic and pharmacodynamic modeling of anti-plasmodial drugs mefloquine plus artesunate: insights on translational application
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01717-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Sabiha R Mim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA. Hauptthemen laut MEDLINE: Mefloquine, Antimalarials, Artemisinins, Malaria. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, CNPq, CAPES.
Abstract (Originalsprache)
A combination between artesunate (AS) and mefloquine (MQ) (ASMQ) is widely employed for the treatment of uncomplicated P. falciparum . Despite this, pharmacokinetic (PK) and underlying relationship between PK and pharmacodynamic (PD) are relatively less known than other standard combination therapy. This study aimed to develop population PK models for ASMQ combination therapy in P. berghei -infected mice and to further characterize the PK/PD relationships by assessing the impact of different dosing strategies through a model-based simulation. Plasma PK was assessed in infected mice receiving a single oral dose of 100 mg/kg AS and 55 mg/kg MQ after allometric scaling to mice dose. A two-compartment model with first-order absorption and linear elimination best described both drugs' concentration-time profiles. PK/PD modeling, performed using a turnover model in MonolixSuite 2024R1, revealed IC₅₀ values of 10.93 nM for artesunate and 29.1 nM for mefloquine, indicating strong potency. Simulations demonstrated that both ASMQ dosing regimens (100/55 and 25/55 mg/kg) resulted in comparable parasitemia suppression (~85%) and sustained efficacy. In contrast, AS monotherapy exhibited a rapid initial parasite clearance, but this was followed by a parasite recrudescence. These findings underscore the value of combination therapy and highlight the utility of integrated PK/PD modeling to inform antimalarial treatment optimization in preclinical studies and support translational application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
- Pharmacy Graduate Program, College of Pharmacy, Federal University of Bahia, Salvador, Brazil.
- Fiocruz, Instituto Gonçalo Moniz, Salvador, Bahia, Brazil.
- Department of Technology and Social Sciences, State University of Bahia, Juazeiro, Bahia, Brazil.
ORCID-Profile: Sabiha R Mim, Diogo Rodrigo Magalhaes Moreira, Francine Johansson Azeredo
Förderung
- CSRD VA
- CNPq
- CAPES
Zitieren
APA
Mim, S. R., Vieira Santos, V., Pereira, L. C., Pica, K., Miranda, A. L. L. S., Quadros, H. C., Moreira, D. R. M., & Azeredo, F. J. (2026). Pharmacokinetic and pharmacodynamic modeling of anti-plasmodial drugs mefloquine plus artesunate: insights on translational application. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01717-25
Vancouver
Mim SR, Vieira Santos V, Pereira LC, Pica K, Miranda ALLS, Quadros HC, et al. Pharmacokinetic and pharmacodynamic modeling of anti-plasmodial drugs mefloquine plus artesunate: insights on translational application. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01717-25
BibTeX
@article{Mim2026,
author = {Mim, Sabiha R and Vieira Santos, Valdeene and Pereira, Laiz Campos and Pica, Kiana and Miranda, Aline Lorena Lourenço Dos Santos and Quadros, Helenita Costa and Moreira, Diogo Rodrigo Magalhaes and Azeredo, Francine Johansson},
title = {Pharmacokinetic and pharmacodynamic modeling of anti-plasmodial drugs mefloquine plus artesunate: insights on translational application},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01717-25}
}
EUVIMED